These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1013895)

  • 41. [Kala-azar in Mediterranean vacationers].
    Treske U; Stanisic M
    Dtsch Med Wochenschr; 1968 Jul; 93(27):1320-3 passim. PubMed ID: 5661700
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapy of cutaneous and visceral leishmaniasis in laboratory animals.
    Beveridge E; Neal RA
    Dermatol Int; 1967; 6(3):163-4. PubMed ID: 5590119
    [No Abstract]   [Full Text] [Related]  

  • 43. [Agranulocytosis in visceral leishmaniasis treated with glucantime].
    Bourée P; Dulac O
    Arch Fr Pediatr; 1977; 34(7):659-62. PubMed ID: 931516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Q&A: Institute for OneWorld Health--Fulfilling the promise of medicine for the developing world. Interview by Kyle Funk.
    Ghosh RS
    Virulence; 2010; 1(5):357-8. PubMed ID: 21178470
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical, hematologic, and biochemical study of a case of kala-azar (visceral leishmaniasis) observed in Belgium].
    Limbos P; Van Ros G
    Rev Med Liege; 1973 Apr; 28(8):249-69. PubMed ID: 4368083
    [No Abstract]   [Full Text] [Related]  

  • 46. [Protozoa "incertae sedis" or particular forms of Leishmania?].
    Addadi K; Hamladji MR; Tabet-Derraz O; Abbadi M
    Arch Inst Pasteur Alger; 1971; 49():129-36. PubMed ID: 5163310
    [No Abstract]   [Full Text] [Related]  

  • 47. American cutaneous leishmaniasis. Inefficacy of metronidazole in treatment.
    Walton BC; Paulson JE; Arjona MA; Peterson CA
    JAMA; 1974 Jun; 228(10):1256-8. PubMed ID: 4406512
    [No Abstract]   [Full Text] [Related]  

  • 48. Congenital visceral leishmaniasis in Ukraine: case report.
    Zinchuk A; Nadraga A
    Ann Trop Paediatr; 2010; 30(2):161-4. PubMed ID: 20522305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnosis and therapy of visceral leishmaniasis].
    Wittermann C; Reindke B; Bienzle U
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):342-3. PubMed ID: 7421849
    [No Abstract]   [Full Text] [Related]  

  • 50. [Montenegro's intradermal test in American cutaneous leishmaniasis after antimonial treatment].
    Mayrink W; Melo MN; da Costa CA; Magalhães PA; Dias M; Coelho MV; Araujo FG; Williams P; Figueiredo YP; Batista SM
    Rev Inst Med Trop Sao Paulo; 1976; 18(3):182-5. PubMed ID: 951561
    [No Abstract]   [Full Text] [Related]  

  • 51. Visceral leishmaniasis: new health tools are needed.
    Hailu A; Musa AM; Royce C; Wasunna M
    PLoS Med; 2005 Jul; 2(7):e211. PubMed ID: 16033309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visceral leishmaniasis: more prevalent and more problematic.
    Baily GG; Nandy A
    J Infect; 1994 Nov; 29(3):241-7. PubMed ID: 7884216
    [No Abstract]   [Full Text] [Related]  

  • 53. Rapidly reversible depression of delayed hypersensitivity in two children with visceral leishmaniasis.
    Ugazio AG; Marchi A; Monafo V
    Infection; 1975; 3(4):231-3. PubMed ID: 1205628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A case of laryngeal leishmaniasis with a long course].
    Ravisse P; Bensimon P; Lapicorey G
    Bull Soc Pathol Exot Filiales; 1984; 77(3):305-11. PubMed ID: 6488420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current concepts in parasitology. Leishmaniasis.
    Marsden PD
    N Engl J Med; 1979 Feb; 300(7):350-2. PubMed ID: 759896
    [No Abstract]   [Full Text] [Related]  

  • 56. [Case of visceral leishmaniasis in the Congo].
    Prevot H; Parmentier R; Bounameaux Y
    Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(4):421-7. PubMed ID: 5760350
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunotherapy for parasitic disease.
    Neva FA
    N Engl J Med; 1990 Jan; 322(1):55-7. PubMed ID: 2104667
    [No Abstract]   [Full Text] [Related]  

  • 58. Design, Conduct, Analysis, and Reporting of Therapeutic Efficacy Studies in Visceral Leishmaniasis: A Systematic Review of Published Reports, 2000-2021.
    Dahal P; Singh-Phulgenda S; Naylor C; Brack M; Chatterjee M; Alves F; Guerin PJ; Stepniewska K
    Am J Trop Med Hyg; 2024 Aug; 111(2):365-376. PubMed ID: 38955166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 60. Mediterranean visceral leishmaniasis: a frequently unrecognized imported disease.
    Mahieu LM; Van Acker KJ
    Am J Dis Child; 1991 Nov; 145(11):1225-7. PubMed ID: 1951208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.